DBV Technologies | Acreedores Comerciales



Trade Creditors Cambio Fecha
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Alnylam Pharmaceuticals USD 88.42M 17.61M 2024-12
Amarin USD 40.51M 13.88M 2024-09
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
DBV Technologies USD 22.5M 2.68M 2024-09
Halozyme Therapeutics USD 10.25M 2.15M 2024-12
Incyte USD 197.46M 18.76M 2024-12
Insmed USD 77.21M 8.54M 2024-12
Ionis Pharmaceuticals USD 42.96M 33.91M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
PTC Therapeutics USD 17.27M 3.98M 2024-12
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
United Therapeutics 6M 357.9M 2024-12



DBV Technologies Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.